Authors: Talley, NJ Verlinden, M Snape, W Beker, JA Ducrotte, P Dettmer, A Brinkhoff, H Eaker, E Ohning, G Miner, PB Mathias, JR Fumagalli, I Staessen, D Mack, RJ

Citation: Nj. Talley et al., Failure of a motilin receptor agonist (ABT-229) to relieve the symptoms offunctional dyspepsia in patients with and without delayed gastric emptying: a randomized double-blind placebo-controlled trial, ALIM PHARM, 14(12), 2000, pp. 1653-1661

Authors: Thjodleifsson, B Beker, JA Dekkers, C Bjaaland, T Finnegan, V Humphries, TJ

Citation: B. Thjodleifsson et al., Rabeprazole versus omeprazole in preventing relapse of erosive or ulcerative gastroesophageal reflux disease - A double-blind, multicenter, European trial, DIG DIS SCI, 45(5), 2000, pp. 845-853

Authors: Dekkers, CPM Beker, JA Thjodleifsson, B Gabryelewicz, A Bell, NE Humphries, TJ

Citation: Cpm. Dekkers et al., Double-blind, comparison of rabeprazole 20 mg versus omeprazole 20 mg in the treatment of erosive or ulcerative gastrooesophageal reflux disease (vol13, pg 49, 1999), ALIM PHARM, 13(4), 1999, pp. 567-567

Authors: Dekkers, CPM Beker, JA Thjodleifsson, B Gabryelewicz, A Bell, NE Humphries, TJ

Citation: Cpm. Dekkers et al., Comparison of rabeprazole 20mg versus omeprazole 20mg in the treatment of active duodenal ulcer: a European multicentre study, ALIM PHARM, 13(2), 1999, pp. 179-186

Authors: Dekkers, CPM Beker, JA Thjodleifsson, B Gabryelewicz, A Bell, NE Humphries, TJ

Citation: Cpm. Dekkers et al., Double-blind, placebo-controlled comparison of rabeprazole 20 mg vs. omeprazole 20 mg in the treatment of erosive or ulcerative gastro-oesophageal reflux disease, ALIM PHARM, 13(1), 1999, pp. 49-57